Nasdaq:US$15.66 (+1.18) | HKEX:HK$24.65 (+0.65) | AIM:£2.44 (+0.15)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice